SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Laura A. Navarro, Alexander Wree, Davide Povero, Michael P. Berk, Akiko Eguchi, Sudakshina Ghosh, Bettina G. Papouchado, Serpil C. Erzurum, Ariel E. Feldstein, Arginase 2 deficiency results in spontaneous steatohepatitis: A novel link between innate immune activation and hepatic de novo lipogenesis, Journal of Hepatology, 2015, 62, 2, 412

    CrossRef

  2. 2
    Petra Hirsova, Gregory J. Gores, Death Receptor-Mediated Cell Death and Proinflammatory Signaling in Nonalcoholic Steatohepatitis, CMGH Cellular and Molecular Gastroenterology and Hepatology, 2015, 1, 1, 17

    CrossRef

  3. 3
    Alexander Wree, Martin Schlattjan, Lars P. Bechmann, Thierry Claudel, Jan-Peter Sowa, Tatjana Stojakovic, Hubert Scharnagl, Harald Köfeler, Hideo A. Baba, Guido Gerken, Ariel E. Feldstein, Michael Trauner, Ali Canbay, Adipocyte cell size, free fatty acids and apolipoproteins are associated with non-alcoholic liver injury progression in severely obese patients, Metabolism, 2014, 63, 12, 1542

    CrossRef

  4. 4
    Li-hong Ding, Dan Liu, Min Xu, Hong Liu, Min Wu, Ri-ning Tang, Lin-li Lv, Kun-ling Ma, Bi-cheng Liu, Enalapril inhibits tubulointerstitial inflammation and NLRP3 inflammasome expression in BSA-overload nephropathy of rats, Acta Pharmacologica Sinica, 2014, 35, 10, 1293

    CrossRef

  5. 5
    Rohini Mehta, Arpan Neupane, Lei Wang, Zachary Goodman, Ancha Baranova, Zobair M Younossi, Expression of NALPs in adipose and the fibrotic progression of non-alcoholic fatty liver disease in obese subjects, BMC Gastroenterology, 2014, 14, 1

    CrossRef

  6. 6
    Alexander Wree, Matthew D. McGeough, Carla A. Peña, Martin Schlattjan, Hongying Li, Maria Eugenia Inzaugarat, Karen Messer, Ali Canbay, Hal M. Hoffman, Ariel E. Feldstein, NLRP3 inflammasome activation is required for fibrosis development in NAFLD, Journal of Molecular Medicine, 2014, 92, 10, 1069

    CrossRef

  7. 7
    Soo Jin Yang, Yunsook Lim, Resveratrol ameliorates hepatic metaflammation and inhibits NLRP3 inflammasome activation, Metabolism, 2014, 63, 5, 693

    CrossRef

  8. 8
    Clifford S. Deutschman, Kevin J. Tracey, Sepsis: Current Dogma and New Perspectives, Immunity, 2014, 40, 4, 463

    CrossRef

  9. 9
    Michal Pawlak, Eric Baugé, William Bourguet, Karolien Bosscher, Fanny Lalloyer, Anne Tailleux, Corinna Lebherz, Philippe Lefebvre, Bart Staels, The transrepressive activity of peroxisome proliferator-activated receptor alpha is necessary and sufficient to prevent liver fibrosis in mice, Hepatology, 2014, 60, 5